san 58035 has been researched along with azalanstat in 1 studies
Studies (san 58035) | Trials (san 58035) | Recent Studies (post-2010) (san 58035) | Studies (azalanstat) | Trials (azalanstat) | Recent Studies (post-2010) (azalanstat) |
---|---|---|---|---|---|
58 | 1 | 12 | 18 | 0 | 5 |
Protein | Taxonomy | san 58035 (IC50) | azalanstat (IC50) |
---|---|---|---|
Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 5.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, A; Hrboticky, N; Kruse, HJ; Weber, PC | 1 |
1 other study(ies) available for san 58035 and azalanstat
Article | Year |
---|---|
Increased cellular triglyceride levels in human monocytic and rat smooth muscle cells after lovastatin.
Topics: Acetates; Amides; Aniline Compounds; Animals; Anticholesteremic Agents; Cell Line; Cholesterol; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins, LDL; Lipoproteins, VLDL; Lovastatin; Mevalonic Acid; Monocytes; Muscle, Smooth; Oleic Acid; Organosilicon Compounds; Rats; Rats, Wistar; Sulfides; Triglycerides | 1997 |